To date, Monday 2 March, eight new patients have been reported to RIVM. This brings the total number of positive tests in the Netherlands to 18.

Three new patients were diagnosed with the novel coronavirus (COVID-19) on March 1st, bringing the number of coronavirus patients in the Netherlands to ten.

On 29 February, a woman in Delft was diagnosed with the novel coronavirus (COVID-19) in the Netherlands. The woman had been in Lombardy, in Northern Italy, last week.

A patient in the Netherlands was diagnosed with the novel coronavirus (COVID-19). Tests confirmed this today.

On Tuesday evening 25 February, it was announced that a German man was tested positive for COVID-19. He would have been in the Netherlands last week.

Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.

Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.

The currently existing models and techniques provide insufficient certainties in the assessment of the harmfulness of nanoparticles and nanomaterials to people and the environment.